Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 11,721 shares at $13.93 ($164K) on 2019-12-03, disclosed to the SEC on 2019-12-04.
Open-market sale of $164k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.17 | 2,565 | $36K | 22.2% |
| 2 | $13.93 | 4,578 | $64K | 38.9% |
| 3 | $13.93 | 4,578 | $64K | 38.9% |
| Total | $13.98 avg | 11,721 | $164K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |